CollPlant Biotechnologies CLGN
NASDAQ CLGN
$3.88 +0.32 (+8.99%)
As of: Oct 20, 2026 · 3:59 PM EDT

CollPlant Biotechnologies (CLGN) Current Debt (2021 - 2022)

Updated

Analysis

CollPlant Biotechnologies (CLGN) Current Debt (2021 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 3.51 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn -5.75 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 208.00 Mn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn -
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn -
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 64.00 Mn
10 CollPlant Biotechnologies 4.68 Mn -17.68 Mn -456,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -87,000.00
Jun 30, 2022 -51,000.00
Mar 31, 2022 -36,000.00
Dec 31, 2021 -151,000.00
Sep 30, 2021 -24,000.00
Jun 30, 2021 -58,000.00
Mar 31, 2021 -16,000.00
API Access

CollPlant Biotechnologies Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=CLGN&period=max&api_key=YOUR_API_KEY